NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
12.99
-0.29 (-2.22%)
Jun 6, 2025, 1:11 PM - Market open
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $425.89 million as of June 6, 2025. Its market cap has increased by 81.20% in one year.
Market Cap
425.89M
Enterprise Value
442.45M
1-Year Change
81.20%
Ranking
Category
Stock Price
$12.99
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $425.89M, an increase of 8.29%. That is a compound annual growth rate of 1.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 431.96M | 29.33% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.01B |
| Johnson & Johnson | 373.18B |
| AbbVie | 334.82B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 271.34B |
| Abbott Laboratories | 233.97B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |